NCT07489937 Supraspinatus Tendon Acute Effects After Two Exercise Exposures: a Crossover Randomized Trial.
| NCT ID | NCT07489937 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Florida |
| Condition | Shoulder Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 24 participants |
| Start Date | 2026-04-20 |
| Primary Completion | 2027-04-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 24 participants in total. It began in 2026-04-20 with a primary completion date of 2027-04-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to understand acute tendon changes after two exercise programs. We will invite individuals with and without shoulder pain to participate in this study. Every individual will participate in both exercise programs separated by up to 15 days. The researcher will evaluate the shoulder tendon using ultrasound before each exercise program and at 1 hour, 6 hours and 24 hours after each exercise program. The researcher will also evaluate self reported pain, pain sensitivity testing, and self reported questionnaires. We will compare the tendon changes after each exercise program, as well as between participants with and without shoulder pain.
Eligibility Criteria
General inclusion criteria 1. Between 18 and 45 years of age 2. Able to perform physical activity with their shoulder (moderate arm exercise for 15 min, such as tennis or housework) General exclusion criteria 1. Shoulder fracture 2. Frozen shoulder (\>50% restriction in shoulder range of motion) 3. Shoulder surgery 4. Full rotator-cuff tears 5. Bilateral shoulder pain 6. Shoulder instability (history or positive apprehension test) 7. Corticosteroid injection in the last 6 weeks 8. Neurological diseases 9. Cardiological diseases 10. Systemic diseases (rheumatic diseases, autoimmune diseases) 11. Uncontrolled diabetes 12. Pregnancy Group-specific inclusion criteria 1. Shoulder pain group: report unilateral shoulder pain with an average shoulder pain score of≥ 3 in the last week. 2. Control group: report no shoulder pain within 6 months.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07489937 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 45 Years, studying Shoulder Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07489937 currently recruiting?
Yes, NCT07489937 is actively recruiting participants. Contact the research team at iraguzzi@ufl.edu for enrollment information.
Where is the NCT07489937 trial being conducted?
This trial is being conducted at Gainesville, United States.
Who is sponsoring the NCT07489937 clinical trial?
NCT07489937 is sponsored by University of Florida. The trial plans to enroll 24 participants.